erlotinib hydrochloride has been researched along with angiogenin in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (angiogenin) | Trials (angiogenin) | Recent Studies (post-2010) (angiogenin) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 935 | 12 | 386 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CT; Chou, CK; Fleming, JB; Fogelman, D; Hsu, JL; Hung, MC; Javle, M; Kang, Y; Katz, MH; Kim, M; Ko, HW; Lee, HH; Li, D; Lim, SO; Liu, CG; Liu, X; Maitra, A; Prakash, LR; Wang, H; Wang, WJ; Wang, YN; Wei, Y; Wu, X; Xia, W; Yang, WH; Yao, J; Ye, Y; Ying, H; Zhu, C | 1 |
1 other study(ies) available for erlotinib hydrochloride and angiogenin
| Article | Year |
|---|---|
Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic Cancer.
Topics: Animals; Binding Sites; Biomarkers; Carcinoma, Pancreatic Ductal; Cattle; Cell Line, Tumor; ErbB Receptors; Erlotinib Hydrochloride; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Mice; Neoplasm Transplantation; Pancreatic Neoplasms; Ribonuclease, Pancreatic; Signal Transduction | 2018 |